The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
Philip Bredin, Jarushka Naidoo(Sidney Kimmel Comprehensive Cancer Center)
Cited by 27
Related Papers
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
|New England Journal of Medicine|2018|2.1k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|897
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|560